All News

Article

ACR23 – Day 1 Report

Jack Cush, MD

ACR 2023 is back in San Diego for its annual convergence of thousands of rheumatologists to partake, discover and learn from thousands of abstracts and hundreds of sessions and presentations. It was a big return for the Poster Hall with rows and rows of research, friends, fellows and poster tours.  Below are a few of my favorite presentations from the posters, Plenary and oral sessions on day one.

Dr. Rachel Tate Tweet
UTSW Dallas study: Health literacy may be essential limiting factor for families w/ children w/ SLE. Other critical barriers to patient care include food security and living costs such as transportation, housing, and utilities. #ACR23 Abs #1029 https://t.co/jtnIgLZQfC @rheumnow https://t.co/A1zr8quSdd
Richard Conway Tweet
@gurdeep_dulay I ask the same question always, why would you stop denosumab? Nothing comes close to fully ameliorating the negative consequences of doing so. Denosumab is for life, until we figure out how to safely get off it. Don't start it unless that is acceptable #ACR23
Anne Troldborg Tweet
#ACR23 #ReviewCourse - By Dr. Francesco Boin. Systemic Sclerosis Screening for Organ Involvement. This slide is a true "take home slide" @ACRheum #ACRambassador https://t.co/4FVYWJjHyV
Dr Gurdeep S Dulay Tweet
#Denosumab and what to do IF you stop it #ACR23 #osteoporosis #Bisphosphonate #CTX https://t.co/qwdQQjJJlb
Dr. Antoni Chan Tweet
Reduced-dose GC regimen in severe GPA or MPS (creatinine >300 umol/L, RTX as induction) associated with increased risk of death, ESKD, progression before remission requiring treatment modification or relapse, Nagle S Abst#0725 #ACR23 #ACRBest @RheumNow https://t.co/ZVZYRnSy3n
David Liew Tweet
drdavidliew
What a talk. @DrPujaMehta1 on the big stage, with a truly inspirational talk in the #ACR23 Daltroy Lecture. If you have any thoughts at all on DEI, or just are curious, you need to watch this. I need to listen to it again, but two initial key points for me: @RheumNow https://t.co/G4lngvpdS7
David Liew Tweet
drdavidliew
Two initial points for me: 1. Challenge how we see all this, lot of current thinking misses the mark 2. Action, not just acknowledgement, but needs to be thoughtful about what it achieves, not just reactive I’m not doing it justice. Listen to the whole thing! #ACR23 @RheumNow https://t.co/ydb8COnqtA
David Liew Tweet
drdavidliew
Colchicine - what a fascinating medicine. From a rheum point of view, interesting to see it play out for secondary prevention coronary artery disease, lot of patients. Great we can share our collective clinical confidence with it with cardiology #ACR23 @US_FDA session @RheumNow https://t.co/Q7zLtyby8l
sheila Tweet
Clinical pearls in #CNS vasculitis: Dr. R.Hajj-Ali 🧠Clinical dx is difficult bec it presents w/ an array of clinical features 🧠CSF analysis essential in dx; can r/o infexns 🧠Nonvasc imaging highly sensitive 🧠biopsy is valuable esp when alt dx is considered #ACR23 @RheumNow https://t.co/QOAfSHn8ND
Eric Dein Tweet
Risk factor for 1st Thrombosis in OB APS Ab#0115 #ACR23 @RheumNow 186 OAPS pts, followed mean 5.4 yrs. 11 thrombotic events Risk factors: Triple pos APS Abs (OR 11.6), hypocomplementemia (OR 9) Low dose Aspirin (OR 0.14), HCQ (OR 0.11) reduced thrombosis #ACRBest https://t.co/y4KaEAZzA7
Richard Conway Tweet
Cowley et al @sharoncowley01 Subclinical GCA in 17.5% with new PMR. Males with higher ESR more likely to have subclinical GCA. Subclinical GCA more axillary artery. Abstr#0747 #ACR23 #ACRbest @RheumNow https://t.co/CghmX1TKpf https://t.co/MJawtslLud
Dr. Antoni Chan Tweet
In young patients who have a spinal MRI, lesions are reported in most patients, and similar in males:females. SIJ MRI findings are reported in one out of three patients, being more frequently in males @DiegoBenavent Abst #160 #ACR23 @RheumNow https://t.co/aF9WnP7jpY https://t.co/E9UuZ0sWZm
Janet Pope Tweet
#Benefits of #hudroxychloroquine - reduced lipids, clots, CV events, infection AND now improved #fatty #liver #NAFLD….@RheumNow #ACR23 @ACRheum https://t.co/Y43JETY6F3
Nouf Al hemmadi Tweet
Sarilumab for relapsing of PMR. Any thing to to taper off prednisone quickly. #ACR23 , year in review. Lost of good studies and smart discussions @RheumNow at Make rheum for PMR month. https://t.co/VyRP8ls3OC
Janet Pope Tweet
If successful you may need how to pronounce these emerging therapeutics in #inflammatory #arthritis @RheumNow #ACR23 @ACRheum https://t.co/aOogwQCsCM
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×